Chemoinformaics analysis of HEXADECA-2-TRANS-9-CIS-DIENE-12,14-DIYNOIC-ACID-ISOBUTYLAMIDE
| Molecular Weight | 252.398 | nRot | 12 |
| Heavy Atom Molecular Weight | 224.174 | nRig | 3 |
| Exact Molecular Weight | 252.209 | nRing | 0 |
| Solubility: LogS | -4.331 | nHRing | 0 |
| Solubility: LogP | 5.639 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 46.9942 |
| nHD | 1 | BPOL | 28.9578 |
| QED | 0.387 |
| Synth | 2.428 |
| Natural Product Likeliness | 1.462 |
| NR-PPAR-gamma | 0.719 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.008 |
| CACO-2 | -4.782 |
| MDCK | 0.0000232 |
| BBB | 0.325 |
| PPB | 0.980395 |
| VDSS | 0.39 |
| FU | 0.0144701 |
| CYP1A2-inh | 0.135 |
| CYP1A2-sub | 0.318 |
| CYP2c19-inh | 0.069 |
| CYP2c19-sub | 0.698 |
| CYP2c9-inh | 0.254 |
| CYP2c9-sub | 0.986 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.313 |
| CYP3a4-inh | 0.066 |
| CYP3a4-sub | 0.048 |
| CL | 1.676 |
| T12 | 0.775 |
| hERG | 0.063 |
| Ames | 0.022 |
| ROA | 0.482 |
| SkinSen | 0.971 |
| Carcinogencity | 0.401 |
| EI | 0.972 |
| Respiratory | 0.958 |
| NR-Aromatase | 0.24 |
| Antiviral | Yes |
| Prediction | 0.77575 |